Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

Fig. 1

A. The amount of E6 oncogene expression in the CaSki cell line showed the most significant reduction in the gene expression at a concentration of 100 pmol. B. E6-siRNA has been proven to decrease E6 oncogene expression in 48 h. The dose of 100 pmol should be determined as the optimum dose in 48 h (*p < 0.05, **p < 0.01, ***p < 0.001)

Back to article page